Turkish Journal of Medical Sciences
Volume 36

Number 6

Article 8

1-1-2006

Effect of Methanolic Extracts of Artemisia aucheri and Camellia
sinensis on Leishmania major (In Vitro)
MEHDI SHARIF
HAJAR ZIAEI
MOHAMMAD AZADBAKHT
AHMAD DARYANI
AKBAR EBADATTALAB

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
SHARIF, MEHDI; ZIAEI, HAJAR; AZADBAKHT, MOHAMMAD; DARYANI, AHMAD; EBADATTALAB, AKBAR;
and ROSTAMI, MASOUMEH (2006) "Effect of Methanolic Extracts of Artemisia aucheri and Camellia
sinensis on Leishmania major (In Vitro)," Turkish Journal of Medical Sciences: Vol. 36: No. 6, Article 8.
Available at: https://journals.tubitak.gov.tr/medical/vol36/iss6/8

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Effect of Methanolic Extracts of Artemisia aucheri and Camellia sinensis on
Leishmania major (In Vitro)
Authors
MEHDI SHARIF, HAJAR ZIAEI, MOHAMMAD AZADBAKHT, AHMAD DARYANI, AKBAR EBADATTALAB, and
MASOUMEH ROSTAMI

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol36/iss6/8

ORIGINAL ARTICLE

Mehdi SHARIF1

Turk J Med Sci
2006; 36 (6): 365-369
© TÜB‹TAK
E-mail: medsci@tubitak.gov.tr

Effect of Methanolic Extracts of Artemisia aucheri and
Camellia sinensis on Leishmania major (In Vitro)

Hajar ZIAEI1
Mohammad AZADBAKHT2
Ahmad DARYANI1
Akbar EBADATTALAB1
Masoumeh ROSTAMI1

1

2

Department of Parasitology and
Mycology, Faculty of Medicine,
Mazandaran University of
Medical Sciences,
Sari - IRAN
Department of Pharmacognocy,
Faculty of Pharmacy,
Mazandaran University of
Medical Sciences,
Sari - IRAN

Aim: Infections caused by protozoa of the genus Leishmania are major worldwide health problems with high
endemicity in developing countries. The incidence of leishmaniasis has increased in the absence of a vaccine.
Usual drugs for treatment of the disease have many side effects; therefore, there is an urgent need to find
new effective alternatives. The plant kingdom is a valuable source of new medicinal agents.
Methods: In this randomized, one-blind clinical trial, the in vitro leishmanicidal effects of Artemisia aucheri
and Camellia sinensis on Leishmania major were evaluated. The methanolic extracts were prepared by
percolation method. The extracts were dried and redissolved in PBS+DMSO 1% solvent. L. major cells treated
with five concentrations (150, 300, 450, 600, and 750 µg/ml) of the extracts and an untreated control group
were used in the study. The number of promastigotes in each concentration was calculated using a
hemocytometer slide at time zero and at 24, 48, and 72 hours after being harvested.
Results: Methanolic extract of A. aucheri inhibited the parasite multiplication at doses of 150, 300 and 450
µg/ml at 48 and 72 hours of culture. Doses of 600 and 750 µg/ml showed the same effect at 24, 48 and 72
hours of culture (P< 0.05). Methanolic extract of C. sinensis showed inhibition of parasite multiplication when
administered at doses of 150, 300, 450, 600 and 750 µg/ml at 72 hours (P<0.05).
Conclusion: These results provide a new perspective on drug development against Leishmania. The extract of
A. aucheri at 750 µg/ml is strikingly potent against Leishmania, inhibiting the growth of promastigotes of L.
major after 72 hours.
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Artemisia aucheri ve Camellia sinensis’in metanolik ekstrelerinin
In vitro ﬂartlarda Leishmania major’a Etkisi
Giriﬂ ve Amaç: Leishmania grubunun yol açt›¤› enfeksiyonlar özellikle geliﬂmekte olan ülkelerde ciddi bir
problemdir. Aﬂ› yoklu¤unda enfeksiyon s›kl›¤›da artm›ﬂt›r. Tedavi amac›yla kullan›lan ilaçlar›n yan etkileri son
derece fazlad›r, bu nedenle, etkin alternatiflere acilen gereksinim vard›r. Yeni ilaçlar için bitkiler en önemli
kaynakt›r.
Yöntem ve Gereç: Bu randomize tek-kör çal›ﬂmada Artemisia aucheri ve Camellia sinensis’in Leishmania major
üzerindeki etkileri araﬂt›r›lm›ﬂt›r. Metanolik ekstreler perkolasyon yçntemi ile haz›rland›. Ekstreler kurutuldu
ve % 1’lik PBS+DMSO’da çözüldü. L. major hücreleri ekstrelerin beﬂ farkl› konsantrasyonuna (150, 300, 450,
600, and 750 µg/ml) maruz b›rak›ld› ve sonuçlar tedavi edilmemiﬂ kontrol grubu ile karﬂ›laﬂt›r›ld›. Her
konsantrasyondaki promastigot say›s› 0, 24, 48,ve 72 saat sonra hemositometre kullan›larak hesapland›.
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Bulgular: A. aucheri’nin metanolik ekstresi 48 ve 72. saatteki kültürlerde 150, 300 ve 450 µg/ml dozlar›nda
parazitin ço¤almas›n› inhibe etti. 600 ve 750 µg/ml dozlar kültürün 24, 48 ve 72. saatlerinde ayn› etkiyi
gösterdi(p< 0.05). C. sinensis’in metanolik ekstreleri 150, 300, 450, 600 ve 750 µg/ml dozlarda ve sadece
72 satte parazitin ço¤almas›n› inhibe etti(p<0.05).
Sonuç: Bu veriler Leishmania‘ya karﬂ› ilaç geliﬂtirilmesi için yeni bir bak›ﬂ aç›s› göstermiﬂtir. A. aucheri ekstresi
750 µg/ml dozunda is strikingly potent against Leishmania’ya karﬂ› son derece etkilidir ve 72 saatte L. major
promastigotlar›n›n geliﬂimini inhibe eder.
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Introduction
Leishmaniasis is a disease caused by hemoflagellate protozoa species of the genus
Leishmania (1). The reservoirs of the disease are rodents, dogs, sanguine marsupials and
other wild animals. The disease is transmitted by mosquitoes of the genera Lutzomyia
365
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and Phlebotomus. According to the World Health
Organization, 88 countries are affected by leishmaniasis,
with approximately 350 million people at risk.
Comprehending 12 million infected cases, the incidence is
increasing worldwide with 1-2 million new cases
registered annually, despite efforts being made to fight
the disease (2). Leishmaniasis encompasses three clearly
distinguishable clinical manifestations: generalized
visceral infection (visceral leishmaniasis or “Kala-azar”),
cutaneous leishmaniasis (oriental button), and
mucocutaneous leishmaniasis (ulceration of the skin and
hyper-development of the mucous membrane) (3).
Leishmaniasis can be controlled mainly by vector and
reservoir control and infected case management. The first
two approaches are either impractical or expensive,
leaving only the case control as the most effective
strategy (2).
The best drug for the treatment of leishmaniasis is the
pentavalent antimonies, which have been in use for more
than 50 years. High failure rates and relapses are
observed, particularly in treating co-infected patients,
using these drugs (4). Clinical reports indicate that a large
proportion of the cases are becoming unresponsive to
chemotherapy. Variable efficacy, toxicity, requirement of
long courses of parenteral administration and drug
resistance, or combinations of these factors, have been
reported. Pentavalent antimonies are still the first choice
among drugs used for the treatment of leishmaniasis,
despite cardiac and renal toxicity. There is also restriction
in prescribing these drugs for systemic use (5).
Folk medicine is often a good source of bioactive
substances potentially useful against many diseases,
including leishmaniasis. These plants have offered many
substances that are claimed to be promising for the
synthesis of new classes of antileishmanial
chemotherapeutic drugs (6). Most people living in
developing countries are almost completely dependent on
traditional medical practices for their primary health care
needs, and more plants are discovered to be the main
source of drug therapy in traditional medicine. The
recognition and validation of traditional medical practices
and the search for plant-derived drugs could lead to new
strategies for leishmaniasis control.
Phytomedicine originated from China with the
Artemisia annua, a plant that was traditionally used as an
antipyretic (7). Artemisinin has been shown conclusively
to pose anti-malarial activity. It is effective against both
366
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drug-resistant and cerebral malaria-causing strains of
Plasmodium falciparum (8). The Artemisia aucheri is an
indigenous plant very abundant in the north of Iran (9).
Trypanocidal action of green tea catechins (Camellia
sinensis) against two different developmental stages of
Trypanosoma cruzi was reported (2). Green tea is an
audiometric local plant and is also very abundant in
northern Iran. This study intended to verify
ethnopharmacological use of selected traditionally
administered plants of Iran, especially plants that are
employed for treatment of leishmaniasis and similar
diseases. Ethnobotanical information thus serves as a
basis for the selection of the plants of choice.

Materials and Methods
Collection of plants
The aerial parts of A. aucheri were collected from Sari
city and green leaves of C. sinensis from Lahijan city in
July 2004. Both cities are in the north of Iran. The plants
were authenticated by the Botany Division of the
Pharmacognosy Department, Mazandaran University of
Medical Sciences, Iran. A voucher specimen is kept in the
herbarium of the Department.

Extraction
Shade-dried and powdered parts of the plants were
placed in a glass percolator with methanol (Merck) and
were allowed to stand at room temperature for about 48
h (in dark place). The percolates were collected and
subjected to fractionation (10). The methanolic extracts
were concentrated under vacuum using rotavaporator at
40ºC, then dissolved in dimethyl sulfoxide (DMSO) +
phosphate buffered saline (PBS) and diluted with RPMI1640 medium to the highest concentration. Required
quantities of the extract were weighed, dissolved in
DMSO + PBS, crushed in a pestle mortar and taken to
final concentrations using sterile triple distilled water.
DMSO standard solutions of the appropriate extract were
diluted with lyses buffer (1000 v/v) to yield
corresponding sample solutions.

Parasite culture
Promastigotes of Leishmania major (strain) were
maintained by RPMI-1640 medium supplemented with
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10% bovine serum (FBS) at 26 ºC. L. major promastigote
(1×106 parasites/ml) were incubated at 26 ºC for 24, 48,
and 72 h in fresh medium, in absence or presence of
several concentrations (150, 300, 450, 600, 700 mg/ml)
of the methanolic extracts. Intact live L. major
promastigotes in the stationary growth phase were added
to the plate well. A negative control (without plant
extracts), and positive control (with Glucantime: 150
mg/ml) were included in the study.

Statistical analysis
All experiments were performed in triplicate. The
mean and standard error of at least three experiments
were determined. Statistical analysis of the differences
between mean values obtained from experimental groups
was done by means of Student’s t-test. P values of 0.05
or less were considered significant.

Results
Inhibition of parasite growth
Different parts (stems, leaves) of the selected plant
species were extracted and five concentrations (Tables 1
and 2) were used to assess their antileishmanial activity.
The methanolic extracts of A. aucheri and C. sinensis were
capable of completely abrogating the cellular growth of L.
major promastigotes.

Table 1.
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Antileishmanial activity
Tables 1 and 2 show the time course of the viability
of L. major promastigotes in the absence or presence of
methanolic extracts of A. aucheri and C. sinensis. 750
µg/ml methanolic extract of A. aucheri was able to kill
about 25% of both developmental stages of the parasite
after 72 h. Corroborating this result, microscopic
observations showed mainly complete lyses of
promastigotes after treating with 750 mg/ml of A.
aucheri extract for 72 h. The results of the
antileishmanial screenings are shown in Tables 1 and 2.

Discussion
There is a general lack of effective and inexpensive
chemotherapeutic agents for treating protozoa parasitic
diseases, including leishmaniasis (3). Pentavalent
antimonial drugs are the first-line treatment for
leishmaniasis in most affected areas, with amphotericin B
and pentamidine being used as alternative drugs (10).
These agents are not active orally and require long-term
parenteral administration. They also have important side
effects and are expensive. In addition, resistance to these
compounds has become a serious problem. Therefore,
new drugs are urgently required (11). In this sense, new
drugs of herbal origin from the north of Iran discovered
through ethnopharmacological studies have shown
interesting leishmanicidal activities. Extracts from the

Effect of different concentrations of Camellia sinensis methanolic extract in DMSO 1% and PBS buffer on the number of Leishmania major
promastigotes in comparison to controls.
Number of parasites (hours)

Extract concentrations
and controls

Beginning of culture

24 h

48 h

72 h

Culture medium (Negative control)

390000

410000

410000

570000

DMSO+PBS buffer

410000

400000

410000

520000

Glucantime

450000

110000

100000

60000

150 mg/ml extract

440000

360000

350000

200000

300 mg/ml extract

460000

390000

260000

240000

450 mg/ml extract

450000

220000

220000

200000

600 mg/ml extract

461000

300000

190000

120000

750 mg/ml extract

460000

290000

200000

120000

(Positive control)
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Effect of different concentrations of Artemisia aucheri methanolic extract in DMSO 1% and PBS buffer on the number of Leishmania major
promastigotes in comparison to controls.
Number of parasites (hours)

Extract concentrations
and controls

Beginning of culture

24 h

48 h

72 h

Culture medium (Negative control)

390000

410000

410000

570000

DMSO+PBS buffer

410000

400000

410000

520000

Glucantime (Positive control)

450000

110000

100000

60000

150 mg/ml extract

560000

90000

50000

50000

300 mg/ml extract

590000

90000

50000

50000

450 mg/ml extract

610000

100000

40000

30000

600 mg/ml extract

590000

50000

40000

30000

750 mg/ml extract

460000

50000

30000

10000

aerial parts of A. aucheri and leaves of C. sinensis
displayed in vitro activity at concentrations of 150, 300,
450, 500, 750 µg/ml against promastigotes of L. major,
leading to a complete disruption of the nucleus, followed
by cell lyses. In the present work, a novel pharmacological
activity was obtained from the methanolic extract of
these plants. Our initial observation is that the crude
extracts of A. aucheri and C. sinensis strongly inhibited
the in vitro growth of L. major promastigotes. A
bioassay-guided fractionation of the antileishmanial
activity is then recommended. The methanolic extract
showed inhibitory activity against developmental stages
of L. major; after 24, 48, 72 h of culture in fresh medium
incubation, the parasites showed irreversible damages,
suggesting a metabolic injury. These results were
corroborated by lyses of promastigote cells. A. aucheri
contains
0.3-0.5%
artemisinin
and
other
sesquiterpenelactone derivatives. These compounds have
antihelmintic activity. Thus, the effect of A. aucheri on L.
major in this research may be due to these compounds. C.

sinensis has alkaloids such as caffeine and tannins
(catechins). Tannins have antimicrobial, antiviral, and
antiprotozoal activity. Therefore, the effect of C. sinensis
on L. major observed in this research may well be because
of these compounds.
Our results revealed a novel pharmacological activity
against L. major and suggest that these methanolic
extracts have the potential of being used as topical
application in wound healing. The results presented here
provide motivation for further exploration of these
compounds, particularly as antileishmanial agents.
Laboratory synthesis and the possibility of modifying the
chemical structure of methanolic extracts are important
advantages for the development of new antileishmanial
agents using these plants.
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